Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease.
Saved in:
| Title: | Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease. |
|---|---|
| Authors: | Soto-Catalán, Manuel1,2 (AUTHOR) manuel.sotoc@quironsalud.es, Opazo-Ríos, Lucas1,3 (AUTHOR) lopazo@udla.cl, Quiceno, Hernán4 (AUTHOR) hernan.quiceno@fjd.es, Lázaro, Iolanda5 (AUTHOR) iolan.lazaro@researchmar.net, Moreno, Juan Antonio6,7 (AUTHOR) juan.moreno@uco.es, Gómez-Guerrero, Carmen1,2 (AUTHOR) cgomez@fjd.es, Egido, Jesús1,2 (AUTHOR) jegido@fjd.es, Mas-Fontao, Sebastian1,2,8 (AUTHOR) jegido@fjd.es |
| Source: | International Journal of Molecular Sciences. Mar2024, Vol. 25 Issue 5, p2961. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 16616596 |
|---|---|
| DOI: | 10.3390/ijms25052961 |
